Centamin Egypt Limited
03 February 2003
Centamin Egypt Limited
Re. Underwriting of Listed Options
Please be advised that in accordance with the terms of the Underwriting
Agreements entered into between Centamin Egypt Limited (Centamin) and Williams
de Broe Plc (WdeB), Argonaut Capital Limited (ACL) and Southern Cross Equities
Limited (SCE), collectively the Underwriters of the 3rd March 2003 Options, that
Centamin has formally notified the Underwriters in writing that 58,808,454
options remain unexercised as at the 3rd February 2003.
The Underwritten Amount for each Underwriter is therefore as follows:-
Williams de Broe Plc 29,404,227 options @ A$0.20cents = A$5,880,845.40;
Argonaut Capital Limited 14,702,113 options @ A$0.20 cents = A$2,940,422.60;
Southern Cross Equities Limited 14,702,114 options @ A$0.20 cents = A$2,940,422.80.
We are extremely pleased that approximately 47% of holders have elected to
exercise their options well ahead of the expiry date. We regard this as a
strong endorsement by the investors of the Company's activities in the Eastern
Desert of Egypt, in particular the progress achieved toward the development of
the Sukari Gold Project.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.